|
1
|
Samant H, Asafo-Agyei KO and Garfield K:
Portal Vein Thrombosis. StatPearls Publishing LLC, 2021.
|
|
2
|
Iorga RA, Bratu OG, Marcu RD, Constantin
T, Mischianu DLD, Socea B, Gaman MA and Diaconu CC: Venous
thromboembolism in cancer patients: Still looking for answers. Exp
Ther Med. 18:5026–5032. 2019.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Wu M, Schuster M and Tadros M: Update on
management of portal vein thrombosis and the role of novel
anticoagulants. J Clin Transl Hepatol. 7:154–164. 2019.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Ponziani FR, Zocco MA, Campanale C,
Rinninella E, Tortora A, Di Maurizio L, Bombardieri G, De
Cristofaro R, De Gaetano AM, Landolfi R and Gasbarrini A: Portal
vein thrombosis: Insight into physiopathology, diagnosis, and
treatment. World J Gastroenterol. 16:143–155. 2010.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Kumar A, Sharma P and Arora A: Review
article: Portal vein obstruction-epidemiology, pathogenesis,
natural history, prognosis and treatment. Aliment Pharmacol Ther.
41:276–292. 2015.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Manescu-Avram GV, Diaconu C, Voicu L,
Jinga M, Ionita Radu F, Costache DO and Costache RS: Hepatocellular
carcinoma-A review. Rom J Mil Med. 120:27–33. 2017.
|
|
7
|
Stine JG, Argo CK, Pelletier SJ, Maluf DG,
Caldwell SH and Northup PG: Advanced non-alcoholic steatohepatitis
cirrhosis: A high-risk population for pre-liver transplant portal
vein thrombosis. World J Hepatol. 9:139–146. 2017.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Stine JG, Shah NL, Argo CK, Pelletier SJ,
Caldwell SH and Northup PG: Increased risk of portal vein
thrombosis in patients with cirrhosis due to nonalcoholic
steatohepatitis. Liver Transpl. 21:1016–1021. 2015.PubMed/NCBI View
Article : Google Scholar
|
|
9
|
Ioniță Radu F, Jinga M, Nuță P, Costache
RS, Bucurica S, Macadon B, Balaban V and Pătrășescu M: Nonalcoholic
fatty liver disease-an etiological approach. Rom J Mil Med.
117:33–39. 2014.
|
|
10
|
Okuda K, Ohnishi K, Kimura K, Matsutani S,
Sumida M, Goto N, Musha H, Takashi M, Suzuki N and Shinagawa T: ,
et al: Incidence of portal vein thrombosis in liver
cirrhosis. An angiographic study in 708 patients. Gastroenterology.
89:279–286. 1985.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Violi F, Corazza RG, Caldwell SH,
Perticone F, Gatta A, Angelico M, Farcomeni A, Masotti M, Napoleone
L, Vestri A, et al: Portal vein thrombosis relevance on liver
cirrhosis: Italian venous thrombotic events registry. Intern Emerg
Med. 11:1059–1066. 2016.PubMed/NCBI View Article : Google Scholar
|
|
12
|
DeLeve LD and Valla DC, Garcia-Tsao G,
Intagliata NM, Superina RA, Roberts LN, Lisman T and Valla DC:
American Association for the Study Liver diseases. Vascular
disorders of the liver. Hepatology. 49:1729–1764. 2009.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Dentali F, Galli M, Gianni M and Ageno W:
Inherited thrombophilic abnormalities and risk of portal vein
thrombosis: A meta-analysis. Thromb Haemost. 99:675–682.
2008.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Qi X, Chen H and Han G: Effect of
antithrombin, protein C and protein Son portal vein thrombosis in
liver cirrhosis: A meta-analysis. Am J Med Sci. 346:38–44.
2013.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Dentali F, Squizzato A, Brivio L, Appio L,
Campiotti L, Crowther M, Grandi AM and Ageno W: JAK2V617F mutation
for the early diagnosis of Ph-myeloproliferative neoplasms in
patients with venous thromboembolism: A meta-analysis. Blood.
113:5617–5623. 2009.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Ogren M, Bergqvist D, Bjorck M, Acosta S,
Eriksson H and Sternby NH: Portal vein thrombosis: Prevalence,
patient characteristics and lifetime risk: A population study based
on 23,796 consecutive autopsies. World J Gastroenterol.
12:2115–2119. 2006.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Landman C, Nahon S, Cosnes J, Bouhnik Y,
Brixi-Benmansour H, Bouguen G, Colombel JF, Savoye G, Coffin B,
Abitbol V, et al: Portomesenteric vein thrombosis in patients with
inflammatory bowel disease. Inflamm Bowel Dis. 19:582–589.
2013.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Al-Azzawi Y, Al-Abboodi Y, Fasullo M and
Kheder J: Risk factors stratifications for portal venous thrombosis
(PVT). J Liver. 6(208)2007.
|
|
19
|
Fujiyama S, Saitoh S, Kawamura Y, Sezaki
H, Hosaka T, Akuta N, Kobayashi M, Suzuki Y, Suzuki F, Arase Y, et
al: Portal vein thrombosis in liver cirrhosis: Incidence,
management, and outcome. BMC Gastroenterol. 17(112)2017.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Popescu A, Gavrilă A, Nuță P, Costache RS,
Jinga M, Bucurică S, Macadon B, Pătrășescu M and Ioniță Radu F:
Case report-hepatocytolytic syndrome hiding mesenteric venous
ischemia. Rom J Mil Med. 118:44–48. 2015.
|
|
21
|
Ponziani FR, Zocco MA, Garcovich M,
D'Aversa F, Roccarina D and Gasbarrini A: What we should know about
portal vein thrombosis in cirrhotic patients: A changing
perspective. World J Gastroenterol. 18:5014–5020. 2012.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Francoz C, Valla D and Durand F: Portal
vein thrombosis, cirrhosis, and liver transplantation. J Hepatol.
57:203–212. 2012.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Simsek E, Yesilyurt A, Pinarli F, Eyerci N
and Ulus AT: Combined genetic mutations have remarkable effect on
deep venous thrombosis and/or pulmonary embolism occurrence. Gene.
536:171–176. 2014.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Amitrano L, Guardascione MA, Brancaccio V,
Margaglione M, Manguso F, Iannaccone L, Grandone E and Balzano A:
Risk factors and clinical presentation of portal vein thrombosis in
patients with liver cirrhosis. J Hepatol. 40:736–741.
2004.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Martinelli I, Primignani M, Aghemo A,
Reati R, Bucciarelli P, Fabris F, Battaglioli T, Dell'Era A and
Mannucci PM: High levels of factor VIII and risk of extra-hepatic
portal vein obstruction. J Hepatol. 50:916–922. 2009.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Turon F, Cervantes F, Colomer D, Baiges A,
Hernández-Gea V and GarciaPagán JC: Role of calreticulin mutations
in the aetiological diagnosis of splanchnic vein thrombosis. J
Hepatol. 62:72–74. 2015.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Draghici T, Negreanu L, Bratu OG, Stoian
AP, Socea B, Neagu TP, Stanescu AMA, Manuc D and Diaconu CC:
Paraneoplastic syndromes in digestive tumors: A review. Rom
Biotechnol Lett. 24:813–819. 2019.
|
|
28
|
Khoury T, Ayman AR, Cohen J, Daher S,
Shmuel C and Mizrah M: The complex role of anticoagulation in
cirrhosis: An updated review of where we are and where we are
going. Digestion. 93:149–159. 2016.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Sarin SK, Philips CA, Kamath PS, Choudhury
A, Maruyama H, Nery FG and Valla DC: Toward a comprehensive new
classification of portal vein thrombosis in patients with
cirrhosis. Gastroenterology. 151:574–577. 2016.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Plessier A, Darwish-Murad S,
Hernandez-Guerra M, Consigny Y, Fabris F, Trebicka J, Heller J,
Morard I, Lasser L, Langlet P, et al: Acute portal vein thrombosis
unrelated to cirrhosis: A prospective multicenter follow-up study.
Hepatology. 51:210–218. 2010.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Chawla YK and Bodh V: Portal vein
thrombosis. J Clin Exp Hepatol. 5:22–40. 2015.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Amitrano L and Guardascione MA: Management
of portal vein thrombosis in cirrhotic patients. Mediterr J Hematol
Infect Dis. 1(e2009014)2009.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Cagin YF, Atayan Y, Erdogan MA, Dagtekin F
and Colak C: Incidence and clinical presentation of portal vein
thrombosis in cirrhotic patients. Hepatobiliary Pancreatic Dis Int.
15:499–503. 2016.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Faccia M, Ainora ME, Ponziani FR, Riccardi
L, Garcovich M, Gasbarrini A, Pompili M and Zocco MA: Portal vein
thrombosis in cirrhosis: Why a well-known complication is still
matter of debate. World J Gastroenterol. 25:4437–4451.
2019.PubMed/NCBI View Article : Google Scholar
|
|
35
|
De Gaetano AM, Lafortune M, Patriquin H,
De Franco A, Aubin B and Paradis K: Cavernous transformation of the
portal vein: Patterns of intrahepatic and splanchnic collateral
circulation detected with Doppler sonography. AJR Am J Roentgenol.
165:1151–1155. 1995.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Yerdel MA, Gunson B, Mirza D, Karayalçin
K, Olliff S, Buckels J, Mayer D, McMaster P and Pirenne J: Portal
vein thrombosis in adults undergoing liver transplantation: Risk
factors, screening, management, and outcome. Transplantation.
69:1873–1881. 2000.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Iftimie G, Pantea Stoian A, Socea B,
Motofei I, Marcu D, Costache RS and Diaconu C: Complications of
systemic lupus erythematosus: A review. Rom J Mil Med. 121:9–15.
2018.
|
|
38
|
Young K and Wong R: Evaluation and
management of acute and chronic portal vein thrombosis in patients
with cirrhosis. Clin Liver Dis (Hoboken). 10:152–156. 2017.
|
|
39
|
Sarin SK and Kumar A: Noncirrhotic portal
hypertension. Clin Liver Dis. 10:627–651. 2006.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Zocco MA, Di Stasio E, De Cristofaro R,
Novi M, Ainora ME, Ponziani F, Riccardi L, Lancellotti S,
Santoliquido A, Flore R, et al: Thrombotic risk factors in patients
with liver cirrhosis: Correlation with MELD scoring system and
portal vein thrombosis development. J Hepatol. 51:682–689.
2009.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Margini C and Berzigotti A: Portal vein
thrombosis: The role of imaging in the clinical setting. Dig Liver
Dis. 49:113–120. 2017.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Khanna R and Sarin SK: Idiopathic portal
hypertension and extrahepatic portal venous obstruction. Hepatol
Int. 12 (Suppl 1):S148–S167. 2018.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Diaconu C, Ciocîrlan M, Jinga M, Costache
RS, Constantinescu G, Ilie M and Diculescu M: Ectopic pancreas
mimicking gastrointestinal stromal tumor in the stomach fundus.
Endoscopy. 50:E186–E187. 2018.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Langabeer SE: CALR mutation analysis is
not indicated in patients with splanchnic vein thrombosis without
evidence of a myeloproliferative neoplasm: A micro-review. Ann
Gastroenterol. 29:557–558. 2016.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Diaconu C, Ioniță Radu F, Jinga M, Nuță P,
Bucurică S, Macadon B, Pătrășescu M, Popescu A, Balaban V, Voicu L,
et al: From liver biopsy to non-invasive markers in evaluating
fibrosis in chronic liver disease. Rom J Mil Med. 118:5–12.
2015.
|
|
46
|
Vladut C, Ciocirlan M, Bilous D, Sandru V,
Stan-Ilie M, Panic N, Becheanu G, Jinga M, Costache RS, Costache
DO, et al: An overview on primary sclerosing cholangitis. J Clin
Med. 9(754)2020.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Joppa SA, Salciccioli J, Adamski J, Patel
S, Wysokinski W, McBane R, Al-Saffar FR, Esser H and Shamoun F: A
practical review of the emerging direct anticoagulants, laboratory
monitoring, and reversal agents. J Clin Med. 7(29)2018.PubMed/NCBI View Article : Google Scholar
|
|
48
|
De Gottardi A, Trebicka J, Klinger C,
Plessier A, Seijo S, Terziroli B, Magenta L, Semela D, Buscarini E,
Langlet P, et al: Antithrombotic treatment with direct-acting oral
anticoagulants in patients with splanchnic vein thrombosis and
cirrhosis. Liver Int. 37:694–699. 2017.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Laslo CL, Bacalbasa N, Stanescu AMA,
Carsote M, Bungau S, Rus M, Bratu OG and Diaconu CC: New oral
anticoagulants-possible extension to other indications (Review).
Exp Ther Med. 20:2401–2405. 2020.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Qi X, Yang M, Fan D and Han G:
Transjugular intrahepatic portosystemic shunt in the treatment of
Budd-Chiari syndrome: A critical review of literatures. Scand J
Gastroenterol. 48:771–784. 2013.PubMed/NCBI View Article : Google Scholar
|
|
51
|
European Association for the Study of the
Liver. Electronic address: simpleeasloffice@easloffice.eu:.
EASL clinical practice guidelines: Vascular diseases of the liver.
J Hepatol. 64:179–202. 2016.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Senzolo M, Sartori TM, Rossetto V, Burra
P, Cillo U, Boccagni P, Gasparini D, Miotto D, Simioni P,
Tsochatzis E and A Burroughs K: Prospective evaluation of
anticoagulation and transjugular intrahepatic portosystemic shunt
for the management of portal vein thrombosis in cirrhosis. Liver
Int. 32:919–927. 2012.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Scheiner B, Stammet PR, Pokorny S, Bucsics
T, Schwabl P, Brichta A, Thaler J, Lampichler K, Ba-Ssalamah A, Ay
C, et al: Anticoagulation in non-malignant portal vein thrombosis
is safe and improves hepatic function. Wien Klin Wochenschr.
130:446–455. 2018.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Vega JA, Lee YR, McMahan D and Duong HQ:
Monitoring enoxaparin with antifactor Xa levels in severe renal
impairment. J Pharma Care Health Sys. 3(2)2016.
|
|
55
|
Warkentin TE, Pai M and Linkins LA: Direct
oral anticoagulants for treatment of HIT: Update of Hamilton
experience and literature review. Blood. 130:1104–1113.
2017.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Connolly SJ, Milling TJ Jr, Eikelboom JW,
Gibson CM, Curnutte JT, Gold A, Bronson MD, Lu G, Conley PB,
Verhamme P, et al: Andexanet Alfa for acute major bleeding
associated with factor Xa inhibitors. N Engl J Med. 375:1131–1141.
2016.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Smalberg JH, Arends LR, Valla DC,
Kiladjian JJ, Janssen HL and Leebeek FW: Myeloproliferative
neoplasms in Budd-Chiari syndrome and portal vein thrombosis: A
meta-analysis. Blood. 120:4921–4928. 2012.PubMed/NCBI View Article : Google Scholar
|
